Terms: = Bone cancer AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911 AND Treatment
28 results:
1. Risk factors for early mortality in elderly patients with unstable isolated C2 odontoid fracture treated with halo-vest or surgery.
Honda A; Iizuka Y; Michihata N; Morita K; Mieda T; Takasawa E; Ishiwata S; Kakuta Y; Tomomatsu Y; Ito S; Inomata K; Matsui H; Fushimi K; Yasunaga H; Chikuda H
Sci Rep; 2023 Oct; 13(1):17962. PubMed ID: 37864100
[TBL] [Abstract] [Full Text] [Related]
2. Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial.
Mileshkin LR; Moore KN; Barnes EH; Gebski V; Narayan K; King MT; Bradshaw N; Lee YC; Diamante K; Fyles AW; Small W; Gaffney DK; Khaw P; Brooks S; Thompson JS; Huh WK; Mathews CA; Buck M; Suder A; Lad TE; Barani IJ; Holschneider CH; Van Dyk S; Quinn M; Rischin D; Monk BJ; Stockler MR
Lancet Oncol; 2023 May; 24(5):468-482. PubMed ID: 37080223
[TBL] [Abstract] [Full Text] [Related]
3. [SURVIVAL OF PEDIATRIC PATIENTS WITH NON-MALIGNANT DISEASES REQUIRING HOSPITALIZATION IN THE INTENSIVE CARE UNIT FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION AND RISK FACTORS FOR MORTALITY].
Zaidman I; Even-Or E; Mandel A; Kleid D; Ben Arush M; Porat I; Gefen A; Stepensky P
Harefuah; 2023 Jan; 162(1):37-41. PubMed ID: 36714940
[TBL] [Abstract] [Full Text] [Related]
4. Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study.
Ferrari A; Chisholm JC; Jenney M; Minard-Colin V; Orbach D; Casanova M; Guillen G; Glosli H; van Rijn RR; Schoot RA; Cameron AL; Rogers T; Alaggio R; Ben-Arush M; Mandeville HC; Devalck C; Defachelles AS; Coppadoro B; Bisogno G; Merks JHM
Lancet Child Adolesc Health; 2022 Aug; 6(8):545-554. PubMed ID: 35690071
[TBL] [Abstract] [Full Text] [Related]
5. Preliminary analysis of distinct clinical and biologic features of bone metastases in melanoma.
Wilson MA; Zhong J; Johannet P; Lee Y; Masub N; Wechter T; Moran U; Berman RS; Shapiro RL; Weber J; Pavlick A; Osman I
Melanoma Res; 2020 Oct; 30(5):492-499. PubMed ID: 32804707
[TBL] [Abstract] [Full Text] [Related]
6. Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis.
Kim Y; Tian Y; Yang J; Huser V; Jin P; Lambert CG; Park H; You SC; Park RW; Rijnbeek PR; Van Zandt M; Reich C; Vashisht R; Wu Y; Duke J; Hripcsak G; Madigan D; Shah NH; Ryan PB; Schuemie MJ; Suchard MA
Sci Rep; 2020 Jul; 10(1):11115. PubMed ID: 32632237
[TBL] [Abstract] [Full Text] [Related]
7. [Spectrum analysis of pathological classification in 463 cases with nasal and paranasal sinuses malignant tumors].
Li J; Yuan H; Li Y; Zhao XQ; Chen L; Han MK; Liu CQ; Liu Q; Wang HT; Zhong Q; Feng B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Dec; 33(12):1176-1180. PubMed ID: 31914269
[No Abstract] [Full Text] [Related]
8. Healthcare resource utilization and costs in patients with multiple myeloma with and without skeletal-related events.
Ailawadhi S; Medhekar R; Princic N; Fowler R; Tran O; Bhowmik D; Panjabi S
J Oncol Pharm Pract; 2020 Jul; 26(5):1070-1079. PubMed ID: 31631810
[TBL] [Abstract] [Full Text] [Related]
9. The prognosis and management of neuroendocrine neoplasms-related metastatic bone disease: lessons from clinical practice.
Alexandraki KI; Pizanias M; Uri I; Thomas D; Page T; Kolomodi D; Low CS; Adesanya O; Tsoli M; Gross DJ; Randeva H; Srirajaskanthan R; Grozinsky-Glasberg S; Kaltsas G; Weickert MO
Endocrine; 2019 Jun; 64(3):690-701. PubMed ID: 30635793
[TBL] [Abstract] [Full Text] [Related]
10. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood cancer Survivor Study cohort.
Gibson TM; Mostoufi-Moab S; Stratton KL; Leisenring WM; Barnea D; Chow EJ; Donaldson SS; Howell RM; Hudson MM; Mahajan A; Nathan PC; Ness KK; Sklar CA; Tonorezos ES; Weldon CB; Wells EM; Yasui Y; Armstrong GT; Robison LL; Oeffinger KC
Lancet Oncol; 2018 Dec; 19(12):1590-1601. PubMed ID: 30416076
[TBL] [Abstract] [Full Text] [Related]
11. Postoperative Complications of Endoscopic Versus Microscopic Transsphenoidal Pituitary Surgery: A Meta-Analysis.
Fang J; Xie S; Li N; Jiang Z
J Coll Physicians Surg Pak; 2018 Jul; 28(7):554-559. PubMed ID: 29950263
[TBL] [Abstract] [Full Text] [Related]
12. Granulocyte colony-stimulating factor-producing pancreatic anaplastic carcinoma in ascitic fluid at initial diagnosis: A case report.
Kubota N; Naito Y; Kawahara A; Taira T; Yamaguchi T; Yoshida T; Abe H; Takase Y; Fukumitsu C; Murata K; Ishida Y; Okabe Y; Kimura Y; Tanigawa M; Mihara Y; Nakayama M; Yamaguchi R; Akiba J; Yano H
Diagn Cytopathol; 2017 May; 45(5):463-467. PubMed ID: 28185423
[TBL] [Abstract] [Full Text] [Related]
13. Factors predicting efficacy and adverse effects of enzalutamide in Japanese patients with castration-resistant prostate cancer: results of retrospective multi-institutional study.
Terada N; Akamatsu S; Okada Y; Negoro H; Kobayashi T; Yamasaki T; Matsui Y; Inoue T; Kamba T; Ogawa O
Int J Clin Oncol; 2016 Dec; 21(6):1155-1161. PubMed ID: 27351872
[TBL] [Abstract] [Full Text] [Related]
14. Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.
Dimopoulos MA; Moreau P; Palumbo A; Joshua D; Pour L; Hájek R; Facon T; Ludwig H; Oriol A; Goldschmidt H; Rosiñol L; Straub J; Suvorov A; Araujo C; Rimashevskaya E; Pika T; Gaidano G; Weisel K; Goranova-Marinova V; Schwarer A; Minuk L; Masszi T; Karamanesht I; Offidani M; Hungria V; Spencer A; Orlowski RZ; Gillenwater HH; Mohamed N; Feng S; Chng WJ;
Lancet Oncol; 2016 Jan; 17(1):27-38. PubMed ID: 26671818
[TBL] [Abstract] [Full Text] [Related]
15. Intermittent versus continuous cyproterone acetate in bone metastatic prostate cancer: results of a randomized trial.
Verhagen PC; Wildhagen MF; Verkerk AM; Vjaters E; Pagi H; Kukk L; Bratus D; Fiala R; Bangma CH; Schröder FH; Mickisch GH
World J Urol; 2014 Oct; 32(5):1287-94. PubMed ID: 24258313
[TBL] [Abstract] [Full Text] [Related]
16. Function after injection of benign bone lesions with a bioceramic.
Fillingham YA; Lenart BA; Gitelis S
Clin Orthop Relat Res; 2012 Jul; 470(7):2014-20. PubMed ID: 22290129
[TBL] [Abstract] [Full Text] [Related]
17. Risk of myocardial infarction, stroke, and fracture in a cohort of community-based breast cancer patients.
Ligibel JA; James O'Malley A; Fisher M; Daniel GW; Winer EP; Keating NL
Breast Cancer Res Treat; 2012 Jan; 131(2):589-97. PubMed ID: 21881937
[TBL] [Abstract] [Full Text] [Related]
18. Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden.
Foukakis T; Fornander T; Lekberg T; Hellborg H; Adolfsson J; Bergh J
Breast Cancer Res Treat; 2011 Nov; 130(2):553-60. PubMed ID: 21617918
[TBL] [Abstract] [Full Text] [Related]
19. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
[TBL] [Abstract] [Full Text] [Related]
20. Precursor B-cell lymphoblastic lymphoma (PBLL) in children: pattern of presentation and outcome.
Belgaumi AF; Al-Kofide A; Sabbah R; Shalaby L
J Egypt Natl Canc Inst; 2005 Mar; 17(1):15-9. PubMed ID: 16353078
[TBL] [Abstract] [Full Text] [Related]
[Next]
